相关实验视频
Updated: Jan 10, 2026
08:56
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
1.2K
老年人骨质疏松症:哈萨克斯坦的一项跨部门研究
Aigul Abduldayeva1, Gulnur Doszhanova1, Saule Iskakova1
1Department of Research Institute of Preventive Medicine Named After Academician E. Dalenov, Astana Medical University, Astana 010000, Kazakhstan.
International journal of environmental research and public health
|November 27, 2025
概括
这项在哈萨克斯坦的研究发现,较高的体重指数 (BMI) 与60岁以上成年人骨质疏松症风险降低有关. 过多的身体脂肪似乎保护骨健康,以及关键营养素和微量元素.
科学领域:
- 老年学和骨健康问题
- 营养科学与新陈代谢
- 骨质疏松症的流行病学
背景情况:
- 骨质疏松症是一个重要的公共卫生问题,特别是在老龄化人口中.
- 身体组成,营养状况和骨健康之间的相互作用需要在不同族群中进一步研究.
- 哈萨克斯坦为研究60岁以上个体的骨健康提供了一个独特的人口统计数据.
研究的目的:
- 评估60岁及以上的哈萨克斯坦成年人的骨健康状况.
- 检查骨质疏松症,体重指数 (BMI),身体组成和营养因素之间的关系.
- 在这个人群中识别骨质疏松症和骨折风险的危险因素.
主要方法:
- 用骨的定量超声波来评估骨强度.
- 使用FRAX工具来评估骨折风险.
- 从61名60-89岁的参与者 (1620名女性,341名男性) 收集了数据.
主要成果:
- 骨质疏松症的患病率在女性中为20.2%,在男性中为15.2%;骨质疏松症影响了两性中超过58%的人.
- 观察到BMI和骨质疏松症之间存在显著的逆相关性,这表明更高的体脂具有保护作用.
- 年龄,身高和体重是骨质疏松症的重要风险因素;特定的营养素和微量元素也起着作用.
结论:
- 较高的BMI和多余的身体脂肪与哈萨克斯坦老年人骨质疏松症风险降低有关.
- 营养因素,包括经典营养素和微量元素,对于骨代谢很重要.
- 对于风险评估而言,FRAX工具非常有价值,未来的研究应该探索新的人类指数.
相关概念视频
01:29Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
186
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
186
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
223
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
223
01:19The Effect of Aging on Tissues
3.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.1K
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
217
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
217
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180